Identification of the first case of germline duplication of BRCA1 exon 13 in an Italian family

[1]  A. Tchirkov,et al.  Gene dosage methods as diagnostic tools for the identification of chromosome abnormalities. , 2008, Pathologie-biologie.

[2]  W. Misdorp,et al.  Tumors of the Mammary Gland , 2008 .

[3]  A. Tutt,et al.  Triple negative tumours: a critical review , 2007, Histopathology.

[4]  A. Whittemore,et al.  Screening for the BRCA1‐ins6kbEx13 mutation: potential for misdiagnosis , 2007, Human mutation.

[5]  J. Benítez,et al.  Pathology and gene expression of hereditary breast tumors associated with BRCA1, BRCA2 and CHEK2 gene mutations , 2006, Oncogene.

[6]  J. Reis-Filho,et al.  Basal-like breast cancer and the BRCA1 phenotype , 2006, Oncogene.

[7]  M. Federico,et al.  Prevalence of BRCA1 genomic rearrangements in a large cohort of Italian breast and breast/ovarian cancer families without detectable BRCA1 and BRCA2 point mutations , 2006, Genes, chromosomes & cancer.

[8]  J. Benítez,et al.  Histopathology of BRCA1- and BRCA2-associated breast cancer. , 2006, Critical reviews in oncology/hematology.

[9]  B. Ward,et al.  Prevalence of five previously reported and recurrent BRCA1 genetic rearrangement mutations in 20,000 patients from hereditary breast/ovarian cancer families , 2005, Genes, chromosomes & cancer.

[10]  S. Mazoyer.  Genomic rearrangements in the BRCA1 and BRCA2 genes , 2005, Human mutation.

[11]  J. Cigudosa,et al.  Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers , 2005, Breast Cancer Research and Treatment.

[12]  Ram Datar,et al.  DNA extraction from archival formalin-fixed, paraffin-embedded tissues: heat-induced retrieval in alkaline solution , 2004, Histochemistry and Cell Biology.

[13]  L. Bégin,et al.  The Prognostic Implication of the Basal-Like (Cyclin Ehigh/p27low/p53+/Glomeruloid-Microvascular-Proliferation+) Phenotype of BRCA1-Related Breast Cancer , 2004, Cancer Research.

[14]  L. Bégin,et al.  Glomeruloid microvascular proliferation is associated with p53 expression, germline BRCA1 mutations and an adverse outcome following breast cancer , 2003, British Journal of Cancer.

[15]  G. Pelosi,et al.  Microallelotyping Defines the Monoclonal or the Polyclonal Origin of Mixed and Collision Endocrine-Exocrine Tumors of the Gut , 2003, Laboratory Investigation.

[16]  S. Narod,et al.  BRCA mutations in Italian breast/ovarian cancer families , 2002, European Journal of Human Genetics.

[17]  R. Start.  AFIP Atlas of Tumor Pathology , 2000 .

[18]  M. Beckmann,et al.  The exon 13 duplication in the BRCA1 gene is a founder mutation present in geographically diverse populations. The BRCA1 Exon 13 Duplication Screening Group. , 2000, American journal of human genetics.

[19]  S. Libutti,et al.  Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients: histopathological and molecular genetic analysis. , 1998, The American journal of pathology.

[20]  L. Hood,et al.  Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1. , 1996, Genome research.

[21]  D. Stoppa-Lyonnet,et al.  An Alu-mediated 6-kb duplication in the BRCA1 gene: a new founder mutation? , 1999, American journal of human genetics.